Streetbeat News

Products Services

BCLI

Brainstorm Cell Therapeutics' stock is up following the announcement of granted patents for its Allogeneic Exosome Platform-Product, aimed at treating neurological disorders.

Portfolio Pulse from Benzinga Newsdesk

December 26, 2023 | 2:07 pm

AMGN

Amgen announced that the FDA has completed its review of the supplemental New Drug Application for full approval of LUMAKRAS (sotorasib), resulting in a Complete Response Letter. The FDA issued a new postmarketing requirement for an additional confirmatory study to be completed by February 2028. The FDA confirmed the dosing of LUMAKRAS at 960 mg once-daily for patients with KRAS G12C-mutated NSCLC under accelerated approval. Over 15,000 patients have received LUMAKRAS worldwide through various programs.

Portfolio Pulse from Happy Mohamed

December 26, 2023 | 2:03 pm

AMD

INTC

NVDA

Nvidia Corp (NASDAQ:NVDA) has seen its stock more than triple in 2023, reaching $488.30 from $143.15. The company's market cap is now $1.2 trillion, with increased earnings and revenue. Nvidia's success is linked to high demand for its graphics cards used in AI training. Technical indicators are bullish, with the 50-day SMA crossing over the 100-day SMA. However, Nvidia's forward P/E of 39.70, while lower than peers AMD and Intel, is still high, and a bearish divergence in the OBV indicator suggests potential consolidation. Nvidia's 2024 guidance is optimistic, with expected growth in data center GPU shipments.

Portfolio Pulse from Surbhi Jain

December 26, 2023 | 2:02 pm

MULN

Mullen Automotive, Inc. has delivered 63 more Class 3 electric vehicles to Randy Marion Automotive Group, invoicing a total of $3,969,000. This brings the total delivered to 121 vehicles, valued at $7,623,000. Mullen is on track to deliver 150 vehicles by the end of 2023, as part of Randy Marion's 1,000 vehicle order worth $63 million. Production is based in Tunica, Mississippi, with a planned annual capacity of 3,000 vehicles per shift. The Mullen THREE, a Class 3 EV truck, is designed for urban last-mile delivery with a 125-mile range and a payload of over 5,300 pounds.

Portfolio Pulse from Happy Mohamed

December 26, 2023 | 2:01 pm

GRCL

HOLI

NVDA

SSYS

TSLA

USDT-USD

Sam Altman's Worldcoin outperformed Bitcoin and Ethereum during Christmas as technical indicators turned bullish. Tether issued $1B USDT on Ethereum's network. Solana surpassed $100 with increased network activity, and Dogecoin's growing addresses could signal a rally. Over 90,000 Bitcoin wallets are now worth $1M+. The SEC is in talks with major players regarding a Bitcoin ETF. US markets saw pre-market movement in stocks like Gracell Biotechnologies, Stratasys, and Hollysys Automation Technologies. The FBI is concerned about China's AI misuse for espionage. In tech, Nvidia is poised to become the biggest chipmaker by revenue, and Tesla's stock rebounded post-Christmas. An AI startup backed by LVMH can verify the authenticity of Louis Vuitton bags.

Portfolio Pulse from Akanksha Bakshi

December 26, 2023 | 1:55 pm

MIST

Milestone Pharmaceuticals' stock is trading lower following the FDA's Refusal to File letter for the New Drug Application of etripamil nasal spray, intended to treat paroxysmal supraventricular tachycardia.

Portfolio Pulse from Benzinga Newsdesk

December 26, 2023 | 1:55 pm

ETH-USD

SOL-USD

Cryptocurrency analyst Altcoin Sherpa has increased his holdings in Solana (SOL), despite acknowledging it might not be the best time to buy. He believes SOL will continue its upward trend into 2024, citing its affordability and accessibility for new crypto users. Google search volume for 'Solana' has surged 250% in two months. Solana's price is currently at $122.64, up 7.73% in the last 24 hours, and has increased over 1,000% since the start of the year.

Portfolio Pulse from Mehab Qureshi

December 26, 2023 | 1:54 pm

BMY

RYZB

Bristol Myers Squibb (BMY) is set to acquire RayzeBio (RYZB) for $4.1 billion, enhancing its oncology portfolio with RayzeBio's radiopharmaceutical therapeutics (RPT) platform. The deal, expected to close in the first half of 2024, will be financed mainly through new debt and is anticipated to dilute BMY's non-GAAP diluted EPS by $0.13 in 2024. RYZB shares surged over 100% in premarket trading.

Portfolio Pulse from Vandana Singh

December 26, 2023 | 1:48 pm

SBUX

Major global coffee chains are targeting Singapore for expansion, viewing it as a strategic location for scaling operations. Brands like Luckin Coffee, Kenangan Coffee, Fore Coffee, Tim Hortons, and Louisa Coffee have opened new outlets in Singapore. Despite competition from established brands like Starbucks (NASDAQ:SBUX) and Dunkin' Donuts, these chains see Singapore as a key market for growth. Starbucks plans to enhance customer experience and double hourly income in the U.S. by FY25 to stay competitive.

Portfolio Pulse from Benzinga Neuro

December 26, 2023 | 1:44 pm

SXTP

60 Degrees Pharmaceuticals shares have risen following the announcement of IRB approval for a Phase IIA clinical study of tafenoquine for babesiosis.

Portfolio Pulse from Benzinga Newsdesk

December 26, 2023 | 1:39 pm